Virtu KCG Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,300
Closed -$468K 3636
2015
Q4
$468K Sell
3,300
-1,000
-23% -$133K 0.01% 1624
2015
Q3
$526K Sell
4,300
-800
-16% -$104K 0.01% 1471
2015
Q2
$662K Sell
5,100
-2,500
-33% -$326K 0.01% 1240
2015
Q1
$1.02M Sell
7,600
-200
-3% -$25.8K 0.02% 766
2014
Q4
$977K Buy
7,800
+1,300
+20% +$158K 0.02% 972
2014
Q3
$791K Buy
6,500
+1,700
+35% +$207K 0.02% 1184
2014
Q2
$566K Sell
4,800
-7,900
-62% -$930K 0.01% 1811
2014
Q1
$1.53M Buy
12,700
+9,900
+354% +$1.18M 0.02% 897
2013
Q4
$312K Sell
2,800
-2,400
-46% -$239K ﹤0.01% 2540
2013
Q3
$479K Buy
+5,200
New +$470K 0.01% 2060

Other funds holding TMO

Virtu KCG Holdings's TMO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Thermo Fisher Scientific (TMO) stake by 66% in Q2 2017, selling an estimated $2.87M and leaving 8,640 shares worth $1.51M. The position accounts for 0.04% of the portfolio, ranked #356.

Virtu KCG Holdings first reported a position in TMO in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.88M in Q1 2014. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Virtu KCG Holdings held 8,640 shares of Thermo Fisher Scientific worth $1.51M as of Q2 2017.
  • Virtu KCG Holdings sold 17,060 Thermo Fisher Scientific shares in Q2 2017, an estimated $2.87M.
  • Thermo Fisher Scientific made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #356 holding.
  • Virtu KCG Holdings first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Thermo Fisher Scientific position peaked at $5.88M in Q1 2014.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.